adenosine receptors for treating recurrent tumor growth

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8551972
APP PUB NO 20110166094A1
SERIAL NO

12940457

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method for treating recurrent tumor metastases following liver resection that includes administration of an effective amount of an agonist of A2A adenosine receptors (ARs).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ADENOSINE THERAPEUTICS LLC1670 DISCOVERY DRIVE SUITE 212 CHARLOTTESVILLE VA 22911

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Borel, Rinkes Inne Utrecht, NL 3 17
Kranenburg, Onno Utrecht, NL 3 17
Rieger, Jayson M Charlottesville, US 49 792
van, der Bilt Jarmila Amsterdam, NL 2 17

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 8, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00